12


/ Press Releases
2022/06
TWi’ ANDA for Guanfacine HCl Tablets (equivalent to Tenex®) has been officially approved by US FDA
2022.04
TWi’ ANDA for Fluphenazine HCl Tablets (equivalent to Prolixin®) has been officially approved by US FDA
2022.03
TWi officially launches its Mycophenolic Acid Delayed-Release Tablets in TWi label
2022.01
TWi officially launches an Authorized Generic of Dexilant® (Dexlansoprazole) Delayed-Release Capsules from Takeda
2021-10
TWi’ ANDA for Metformin HCl Extended-Release Tablets (equivalent to Fortamet®) has been officially approved by US FDA